MedTrace Logo

Gain and Loss Framed Text Messaging to Reduce Drinking Among Older Adults

NCT06126107 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 133

Last updated 2025-03-13

No results posted yet for this study

Summary

The goal of this study is to evaluate effectiveness of scalable, tailored text- messaging programs for alcohol use among older adults. This study focuses on gain and loss framing of behavior change goals (i.e., the positives of change and the negatives of remaining with the status quo), critical components of behavioral science and health behavioral interventions. Loss-framing is used to motivate individuals to avoid future problems by focusing on the consequences of no change in behavior, and gain-framing is used to facilitate progress by focusing on the benefits of change. The investigators will design and evaluate three text-messaging programs using a randomized controlled trial: (A) Loss-framed messaging (B) Gain-framed messaging; and (C) Combined (loss and gain) messaging among a sample of 150 older adults with hazardous drinking. Participants will be randomized to one of the three conditions, each of which will include 8 weeks of text-messaging. During the study participants will completed assessments online and via text messages to track drinking.

Conditions

  • Alcohol Consumption

Interventions

BEHAVIORAL

Brief Normative Feedback

Once a participant has completed the assessment of their drinking during the baseline battery, the participant will receive brief normative feedback about how their drinking compares to their peers.

BEHAVIORAL

Loss-framed Text-messaging

Daily text-messages on the consequence of hazardous drinking.

BEHAVIORAL

Gain-framed Text-messaging

Daily text messages on the benefits of reducing drinking to safe guidelines.

Sponsors & Collaborators

  • Hunter College of City University of New York

    lead OTHER

Principal Investigators

  • Alexis Kuerbis, LCSW, PhD · Silberman School of Social Work at Hunter College City, University of New York

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-26
Primary Completion
2024-12-10
Completion
2024-12-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06126107 on ClinicalTrials.gov